EZH2 and metabolic dysfunction-associated steatotic liver disease: EZH2 expression decreased in high-fat/high-fructose diet (HFa/HFr-D) in vivo NAFLD model and palmitic/oleic acid (PA/OA) in vitro lipid accumulation HepG2 model.